Clinical Trials Related to Amyotrophic Lateral Sclerosis

Related studies linked through entity extraction aliases.

An Open-Label Extension for the Phase 2 Study in Early Symptomatic Amyotrophic Lateral Sclerosis Patients on Stable Background Therapy to Assess Bioenergetic Catalysis With CNM-Au8 to Slow Disease Progression in ALS

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Evaluation of the Early Use of the Pressure Relaxer in the Respiratory Impairment of Patients With Amyotrophic Lateral Sclerosis: Multicenter Randomized Controlled Study.

Status: NOT_YET_RECRUITING
Phase: NA

An Intermediate Size Expanded Access Protocol of AMX0035 for ALS

Status: APPROVED_FOR_MARKETING
Phase: N/A

Three Intermediate Expanded Access Protocols (EAP) CNMAu8.EAP01, CNMAu8.EAP02, and CNMAu8.EAP06 for ALS

Status: AVAILABLE
Phase: N/A

A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1

Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)

Status: TERMINATED
Phase: PHASE2

Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

Status: RECRUITING
Phase: N/A

Online Self-Compassion Course for pALS (Compassion pALS)

Status: COMPLETED
Phase: N/A

Triumeq in Amyotrophic Lateral Sclerosis

Status: TERMINATED
Phase: PHASE3

Neurodegenerative Alzheimer's Disease and Amyotrophic Lateral Sclerosis (NADALS) Basket Trial

Status: COMPLETED
Phase: PHASE1/PHASE2

Study to Investigate the Efficacy and Safety of FAB122 (Daily Oral Edaravone) in Patients With Amyotrophic Lateral Sclerosis

Status: COMPLETED
Phase: PHASE3

A 6-Month Extension Study to Assess the Long-Term Safety of Engensis in Amyotrophic Lateral Sclerosis

Status: COMPLETED
Phase: PHASE2

Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis

Status: COMPLETED
Phase: PHASE2

Use of 1 Minute Sit to Stand Test for Physical Capacity and Effort Related Desaturation in Amyotrophic Lateral Sclerosis

Status: NOT_YET_RECRUITING
Phase: N/A

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures

Status: RECRUITING
Phase: N/A

HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose

Status: COMPLETED
Phase: PHASE2/PHASE3

Genetic Study of Amyotrophic Lateral Sclerosis in Norway

Status: RECRUITING
Phase: N/A

Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders

Status: RECRUITING
Phase: N/A

Cell Signaling, Reinnervation and Metabolism in Kennedy Disease and Amyotrophic Lateral Sclerosis (ALS)

Status: RECRUITING
Phase: NA